MAP3K7 and cancer: Indeed, patients with lower levels of POPX2 showed lower overall survival rate and lower relapse-free survival.9 Therefore, a combination therapy targeting TAK1-IKK-NF-κB pathway may help to increase the effectiveness of cancer treatment.